1. FDA approves gepirone extended-release for treatment of major depressive disorder;Gallagher;Pharmacy Times,2023
2. Gepirone hydrochloride: a novel antidepressant with 5-HT1A agonistic properties;Kaur Gill;Drugs Today (Barc),2019
3. Gepirone: after nearly two decades, FDA approves this not-so-new antidepressant;Fava;MGH Psychiatry News,2023
4. Serotonin 2A (5-HT2A) receptor function: ligand-dependent mechanisms and pathways;Raote;Serotonin receptors in neurobiology,2007
5. Buspirone: future directions;Apter;J Clin Psychopharmacol,1999